A new digital resilience course developed by Leeds Teaching Hospitals NHS Trust to help prevent people with multiple sclerosis (MS) from losing their jobs, has seen positive results. As a result it is now…
Continue Reading
Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists…
Continue Reading
Clinicians and researchers at Leeds Teaching Hospitals NHS Trust have developed a new motion detection tool that can help to identify potentially life-changing treatments for a range of conditions including progressive multiple sclerosis, motor…
Continue Reading
Patients seeking neurologic care can face physical, geographical and financial challenges as they deal with chronic and disabling conditions.Telehealth is offering one way forward. In one of the largest studies of outpatient general teleneurology…
Continue Reading
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major…
Continue Reading
Over the last 20 years, scientific and technological advances have created more sophisticated precision medicine solutions that deliver better and more personalized care to patients. This approach has already fundamentally transformed the way we…
Continue Reading
Octave Bioscience, a company focused on delivering precision medicine for neurodegenerative diseases like multiple sclerosis, announced it closed a $30 million extension to its Series B round.Hikma Pharmaceuticals’ venture capital arm, Hikma Ventures, participated…
Continue Reading
The antibody index (AI) is a measure of local antibody synthesis in the central nervous system (CNS) and represents an important and growing tool in neurological diagnostics. Determination of the AI supports diagnosis of…
Continue Reading
Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample from the patient being treated, isolating a sample of…
Continue Reading
